Autopsy Study Finds Replicating SARS-CoV-2 in the Hearts of Long Covid

Hacker News Top Papers

Summary

An autopsy study found replicating SARS-CoV-2 in the hearts of Long COVID patients, associated with cardiac symptoms and gene expression changes, suggesting viral persistence drives Long COVID cardiac pathology.

No content available
Original Article
View Cached Full Text

Cached at: 07/12/26, 10:48 AM

# USCAP 2026 Annual Meeting Source: [https://my.uscap.org/uscap/program/S0tc675/index.cfm?abid=51228&pgid=5167&sid=14770](https://my.uscap.org/uscap/program/S0tc675/index.cfm?abid=51228&pgid=5167&sid=14770) #### Info **Poster Board Number:** 279 **Background:** SARS\-CoV\-2 RNA can persist in tissues long after initial infection, but with unclear significance\. After acute illness, some patients experience persistent symptoms of potential cardiac origin, such as palpitations, chest pain, shortness of breath, and fatigue consistent with cardiac Long COVID \(CLC\)\. Cardiac viral persistence may drive CLC symptoms and could have direct implications for patient care\. We investigated whether the presence of SARS\-CoV\-2 reverse strand, a marker of viral replication, in the left ventricle \(LV\) is associated with CLC, pathologic changes and altered gene expression\. **Design:** We studied 74 decedents ≥60 days from initial infection, who underwent expedited autopsy\. Cardiac LV tissue was subjected to transcriptomic analysis using NanoString nCounter®HOT Panel / Coronavirus Panel Plus\. Viral positivity was defined as detection of reverse strand relative to negative controls, and its associations with clinical and pathologic features were determined\. Differential gene expression \(DGE\) analysis was performed comparing patients with \(V\+\) and without \(V\-\) SARS\-CoV\-2 reverse strand\. Immunohistochemistry \(IHC\) for IRF4 and in\-situ hybridization \(ISH\) for viral spike gene positive strand were performed\. **Results:** Of 74 cases, 11 were V\+and 63 were V\-\. There was no significant difference in demographics, comorbidities, cause of death, initial viral variant, interval from initial infection, vaccination status, and presence of myocarditis\. CLC was seen in 9 \(82%\) of 11 V\+cases and 23 \(37%\) of 63 V\-cases \(p=0\.0075\)\. V\+cases had a shorter interval from last positive swab \(median 299 vs 522 days; p=0\.01\) and a higher prevalence of severe acute COVID\-19 \(30% vs 3%; p=0\.02\)\. V\+hearts showed higher heart\-weight\-to\-LV\-wall\-thickness ratios \(mean 437 vs 340 g/cm; p=0\.005\), more frequent LV dilatation \(64% vs 24%, p=0\.01\), and more frequent pericardial fluid ≥30 mL \(40% vs 14%; p=0\.048\)\. SARS\-CoV\-2 ISH was positive in cardiac myocytes in V\+cases\. DGE analysis showed significant alteration in the expression of 44 genes involved in inflammation and host response, particularly interferon regulatory factor 4 \(IRF4\)\. By IHC, IRF4\+cells were seen mainly in the epicardium\. **Figure 1:** [![](https://s3.amazonaws.com/amz.xcdsystem.com/9427052B-EB87-B001-574B51E4E8F34C4B_abstract_File13619/781_Figure1_1002083502.jpg)](https://s3.amazonaws.com/amz.xcdsystem.com/9427052B-EB87-B001-574B51E4E8F34C4B_abstract_File13619/781_Figure1_1002083502.jpg) Click to view full size **Figure 2:** [![](https://s3.amazonaws.com/amz.xcdsystem.com/9427052B-EB87-B001-574B51E4E8F34C4B_abstract_File13620/781_Figure2_1002083509.jpg)](https://s3.amazonaws.com/amz.xcdsystem.com/9427052B-EB87-B001-574B51E4E8F34C4B_abstract_File13620/781_Figure2_1002083509.jpg) Click to view full size **Conclusion:** Detection of SARS\-CoV\-2 reverse strand in the hearts of a subset of patients with CLC provides molecular evidence of viral persistence that may drive the structural and immune changes underlying their symptoms, offering mechanistic insights that could inform new diagnostic and therapeutic strategies\. --- **Disclosures:** Faye Victoria Casimero: None; Aram Krauson: None; Pritha Sen: None; David Milstone: None; Maria Martinez\-Lage: None; Robert Padera:*Consultant*\- Morair; Vergent; Vanessa Hannay: None; Zakir Siddiquee: None; Iris Lopez: None; Mayara Bearse: None; Andrea Troxel:*Other*\- BioAge; Cellectis; Carolyn Glass: None; Thomas Flotte: None; Michelle Lamendola\-Essel: None; Chloe Young: None; Phoebe Del Boccio: None; Paul Benson: None; Jonathan Melamed: None; Avi Rosenberg: None; Silvio Litovsky: None; Richard Moffitt: None; Dezhi Wang: None; Vivian Gainer: None; Ayat Abdelsalam: None; Elizabeth Handel: None; Ben White: None; Ameera Afifi: None; James Stone: None #### Authors ![](https://s3.amazonaws.com/amz.xcdsystem.com/uscap/contact_pictures/Casimero_FayeVictoria_66494_092324113543.jpeg) **Faye Victoria C\. Casimero**, MD Massachusetts General Hospital, Harvard Medical School Medford, MA, United States --- ![](https://ui-avatars.com/api/?name=Aram+Krauson&background=e11b22&color=fff) Aram J\. Krauson, PhD Massachusetts General Hospital Charlestown, MA, United States --- ![](https://ui-avatars.com/api/?name=Pritha+Sen&background=e11b22&color=fff) Pritha Sen, MD Brigham and Women's Hospital Boston, MA, United States --- ![](https://ui-avatars.com/api/?name=David+Milstone&background=e11b22&color=fff) David S\. Milstone, MD, PhD Brigham and Women's Hospital Boston, MA, United States --- ![](https://s3.amazonaws.com/amz.xcdsystem.com/uscap/contact_pictures/MartinezLage_Maria_15266_091324065947.jpeg) Maria Martinez\-Lage, MD Mass General Brigham Boston, MA, United States --- ![](https://my.uscap.org/app/pictures/Padera_Robert_18167_011020023912.png) Robert Padera, MD, PhD Brigham and Women's Hospital Boston, MA, United States --- ![](https://s3.amazonaws.com/amz.xcdsystem.com/uscap/contact_pictures/Hannay_Vanessa_124608_011226115906.jpeg) Vanessa Hannay, MS Massachusetts General Hospital Charlestown, MA, United States --- ![](https://ui-avatars.com/api/?name=Zakir+Siddiquee&background=e11b22&color=fff) Zakir Siddiquee, N/A Massachusetts General Hospital Cambridge, MA, United States --- ![](https://ui-avatars.com/api/?name=Iris+Lopez&background=e11b22&color=fff) Iris A\. Lopez, BA Massachusetts General Hospital Cambridge, MA, United States --- ![](https://s3.amazonaws.com/amz.xcdsystem.com/uscap/contact_pictures/Bearse_Mayara_74447_030121105130.jpeg) Mayara Bearse, MD Cedars\-Sinai Medical Center Beverly Hills, CA, United States --- ![](https://ui-avatars.com/api/?name=Andrea+Troxel&background=e11b22&color=fff) Andrea B\. Troxel, ScD New York University Langone Health New York, NY, United States --- ![](https://my.uscap.org/app/pictures/Glass_Carolyn_40837_021520022405.png) Carolyn Glass, MD, PhD Duke University Medical Center Durham, NC, United States --- ![](https://s3.amazonaws.com/amz.xcdsystem.com/uscap/contact_pictures/Flotte_Thomas_7493_021623020651.png) Thomas J\. Flotte, MD Mayo Clinic Faribault, MN, United States --- ![](https://ui-avatars.com/api/?name=Michelle+Lamendola-Essel&background=e11b22&color=fff) Michelle F\. Lamendola\-Essel, DHSc New York University Langone Health Port Jefferson Station, NY, United States --- ![](https://ui-avatars.com/api/?name=Chloe+Young&background=e11b22&color=fff) Chloe E\. Young, BS New York University Langone Health Ridgewood, NJ, United States --- ![](https://ui-avatars.com/api/?name=Phoebe+Del%20Boccio&background=e11b22&color=fff) Phoebe Del Boccio, PhD, MSc New York University Langone Health Montclair, NJ, United States --- ![](https://s3.amazonaws.com/amz.xcdsystem.com/uscap/contact_pictures/Benson_Paul_74337_111622100906.png) Paul Vincentin Benson, MD The University of Alabama at Birmingham Birmingham, AL, United States --- ![](https://s3.amazonaws.com/amz.xcdsystem.com/uscap/contact_pictures/Melamed_Jonathan_15814_010725112231.png) Jonathan Melamed, MD New York University Long Island Mineola, NY, United States --- ![](https://my.uscap.org/app/pictures/Rosenberg_Avi_20550.jpg) Avi Z\. Rosenberg, MD, PhD Johns Hopkins University School of Medicine Baltimore, MD, United States --- ![](https://s3.amazonaws.com/amz.xcdsystem.com/uscap/contact_pictures/Litovsky_Silvio_53808_022825103109.png) Silvio H\. Litovsky, MD The University of Alabama at Birmingham Birmingham, AL, United States --- ![](https://ui-avatars.com/api/?name=Richard+Moffitt&background=e11b22&color=fff) Richard A\. Moffitt, PhD Emory University School of Medicine Atlanta, GA, United States --- ![](https://ui-avatars.com/api/?name=Dezhi+Wang&background=e11b22&color=fff) Dezhi Wang, MD, MBA The University of Alabama at Birmingham Birmingham, AL, United States --- ![](https://ui-avatars.com/api/?name=Vivian+Gainer&background=e11b22&color=fff) Vivian S\. Gainer, MS Mass General Brigham Somerville, MA, United States --- ![](https://ui-avatars.com/api/?name=Ayat+Abdelsalam&background=e11b22&color=fff) Ayat Abdelsalam, MD The University of Alabama at Birmingham Vestavia hills, AL, United States --- ![](https://ui-avatars.com/api/?name=Elizabeth+Handel&background=e11b22&color=fff) Elizabeth A\. Handel, BS Duke University Pittsboro, NC, United States --- ![](https://ui-avatars.com/api/?name=Ben+White&background=e11b22&color=fff) Ben White, N/A My Institution Is Not Listed deerfield, IL, United States --- ![](https://ui-avatars.com/api/?name=Ameera+Afifi&background=e11b22&color=fff) Ameera Afifi, BS, BA Duke University Durham, NC, NC, United States --- ![](https://my.uscap.org/app/pictures/Stone_James_23227.jpg) James R\. Stone, MD, PhD Massachusetts General Hospital Charlestown, MA, United States

Similar Articles

The Causes of Long Covid

Hacker News Top

An article discussing the underlying causes of Long Covid based on current research.

Heart protection from COVID shots remains amid updates, study finds

Ars Technica

A study of over 1 million VA patients found that the updated 2024–2025 COVID-19 vaccine still provides significant protection against cardiovascular events like heart attack and stroke, especially in people over 75 and those with underlying conditions.

Supercharging Immune Cells May Help Control HIV Long-Term

Wired

Early clinical trial results show that repurposing CAR-T cell therapy, originally used for cancer, can help control HIV long-term. Two patients achieved undetectable HIV levels after a single infusion and stopped medications, suggesting a potential functional cure.